Aurora Spine Grants Stock Options
Aurora Spine Corporation (ASG:CA) Q1 2026 Earnings Call Transcript
Aurora Spine Corporation Announces First Quarter FY26 Financial Results
Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2026 Financial Results
Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2026 Financial Results
Aurora Spine Announces Issuance of Fourth U.S. Patent Covering DEXA Technology® Bone Density-Matched Implants
Aurora Spine Announces Issuance of Fourth U.S. Patent Covering DEXA Technology® Bone Density-Matched Implants
Aurora Spine Corporation (ASG:CA) Q4 2025 Earnings Call Transcript
Aurora Spine Corporation Announces Record Fourth Quarter and FY25 Financial Results
Aurora Spine Corporation Schedules Release of Fourth Quarter and Fiscal 2025 Financial Results
Aurora Spine Corporation to Participate in the 38th Annual ROTH Conference
AURORA SPINE CORPORATION ANNOUNCES AMENDMENT TO LOAN FROM INSIDER
Aurora Spine Announces Issuance of Two U.S. Patents
Aurora Spine Corporation (ASG:CA) Q3 2025 Earnings Call Transcript
Aurora Spine Corporation Announces Record Third Quarter Financial Results
Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting
Aurora Spine Launches New Biologics Portfolio
Aurora Spine Announces Proposed Warrant Extension
Aurora Spine Announces Launch of its DEXA-L™ Anterior Lumbar Interbody Fusion Device
Aurora Spine Corporation (ASG:CA) Q2 2025 Earnings Call Transcript
Aurora Spine Announces Participation in 7th Annual American Society of Pain & Neuroscience Conference
Aurora Spine Announces Initial Surgeries using its AERO™ Lumbar Fusion System
Aurora Spine Surpasses 1,500 Successful Surgeries Using DEXA-C™
Aurora Spine Surpasses Milestone of 2,500 Procedures Using SiLO™ SI Joint Fusion System
Aurora Spine Corporation to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
Aurora Spine Corporation Announces Record First Quarter Financial Results
Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2025 Financial Results
Aurora Spine Corporation (ASAPF) Q4 2024 Earnings Call Transcript
Aurora Spine Corporation Announces Fourth Quarter and Fiscal Year 2024 Financial Results
Aurora Spine Corporation Schedules Release of Fourth Quarter and Fiscal 2024 Financial Results
Aurora Spine Announces Publication of Biomechanical Study Demonstrating Superiority of SiLO TFX™ Sacroiliac Fusion System
Aurora Spine Announces FDA 510(k) Clearance for the AERO™ Facet Fusion System
Aurora Spine to Attend the American Academy of Orthopaedic Surgeons Annual Meeting
Aurora Spine Corporation Announces Completion of Enrollment in Groundbreaking REFINE Study: First Prospective, Multi-Center, Multi-Specialty Study on Lumbar Interlaminar Fusion
Aurora Spine Announces Leadership Promotions: Matt Paxton, Executive Vice President of Sales and Katelyn Sims, Area Vice President of Commercialization and Key Accounts
Aurora Spine Corporation (ASAPF) Q3 2024 Earnings Call Transcript
Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2024 Financial Results
Aurora Spine Corporation Announces Third Quarter 2024 Financial Results
Aurora Spine Corporation Announces Release of its Hydra Osteo Onyx Lumbar System
Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting
Aurora Spine to Host ZOOM Call with Alpha Wolf Trading CEO Tim Weintraut
Aurora Spine Corporation to Attend Latin America Pain Society (LAPS) Conference, Showcasing Innovations in Pain Management and Spine Care for Emerging Markets
Aurora Spine Corporation Announces Second Quarter 2024 Financial Results
Aurora Spine Corporation to Attend Sixth Annual American Society of Pain & Neuroscience Conference
Aurora Spine Corporation Announces First Quarter 2024 Financial Results
Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss First Quarter Fiscal Year 2024 Financial Results
Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2023 Financial Results
Aurora Spine Corporation Celebrates Second Anniversary of Initial Implantation of the World's First Bone Density Matched DEXA-C Cervical Interbody Fusion Device
Aurora Spine's Second Patent Related to DEXA Technology™ Patient-Matched Implant Technology Issued by the United States Patent Office